Resolve storage before the package arrives

Ask the dispensing pharmacy for the storage instructions that apply to the exact formulation being shipped. A nasal spray, an injection and an infusion preparation should not be assigned one universal rule. Instructions for one provider's product may also differ from those for another preparation, even when both are labeled NAD+.

Get a contact for delivery concerns before enrollment. If a shipment is delayed, damaged or arrives in an unexpected condition, the pharmacy needs the product details and shipping history to advise on next steps. Appearance alone does not establish whether a preparation remains suitable for use.

Distinguish the relevant dates

A labeled beyond-use date and a limit after first opening or puncture answer different questions. The first concerns the preparation under its specified conditions; the second can impose an earlier deadline once the container is in use. Ask the pharmacist how those limits apply together and where they appear on the label.

CDC's injection-safety guidance distinguishes single-dose and multidose containers. A patient should not decide a container is reusable merely because liquid remains. The actual labeling and pharmacy instructions matter, and general advice cannot extend a shorter product-specific deadline.

Align a multi-month purchase with fulfillment

A three-month commercial plan does not prove that one opened vial is usable for three months. Ask how many containers are supplied, whether they arrive together or in stages, and how their dates align with the prescribed plan. These are practical questions about usable supply rather than a request to change administration instructions.

A larger order may reduce the advertised cost per unit while increasing the chance of unused medication. Before treating the discount as a saving, understand how the pharmacy expects the supplied containers to be used within their limits. Never extend use just to match a budget assumption.

Plan for travel and missed deliveries

If travel is likely, discuss the storage and transport requirements with the pharmacist in advance. Ask whether a shipment can be rescheduled, how far ahead changes must be requested and whether an alternate address is allowed. A provider's free-shipping statement does not answer those timing questions.

Also identify the policy for replacement if a carrier delay or damaged package creates a concern. Save tracking information and any documentation the pharmacy requests. A replacement policy is a commercial term; the decision whether a product should be used is a pharmacy or clinical question.

Why sourcing belongs in the same conversation

FDA has warned about unsuitable ingredients in sterile NAD+ compounding and described adverse-event reports consistent with excessive endotoxins. That warning makes pharmacy identity and handling questions relevant; it is not evidence that every provider or every batch has the same problem. Do not convert a general alert into an accusation against an unnamed product.

Keep the pharmacy's name, contact information and product label with the order record. If a reaction or product concern occurs, those details can help the treating team investigate. A low advertised price is incomplete information when the reader cannot identify the preparation, its source or the instructions that determine its usable life.

Sources & further reading

Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.

  1. CDC: Preventing unsafe injection practices Public health
  2. FDA: Ingredients suitable for sterile compounding Regulator
  3. AgelessRx NAD+ Injection Provider
  4. FDA: Buying medicine safely from an online pharmacy Regulator